ASX - By Stock
|
CYP |
Re:
Ann: Cynata to Acquire IP from Tekcyte
|
|
ZolRab
|
70 |
15K |
9 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
70
|
15K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
ZolRab
|
609 |
110K |
6 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
609
|
110K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
ZolRab
|
609 |
110K |
1 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
609
|
110K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
ZolRab
|
609 |
110K |
9 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
609
|
110K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
ZolRab
|
609 |
110K |
3 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
609
|
110K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
ZolRab
|
609 |
110K |
8 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
609
|
110K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
ZolRab
|
609 |
110K |
12 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
609
|
110K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
ZolRab
|
609 |
110K |
8 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
609
|
110K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
ZolRab
|
609 |
110K |
10 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
609
|
110K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
ZolRab
|
609 |
110K |
4 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
609
|
110K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
ZolRab
|
33 |
9.1K |
10 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
33
|
9.1K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ZolRab
|
21 |
5.8K |
11 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
21
|
5.8K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
FUJIFILM CDI Facility
|
|
ZolRab
|
3 |
1.3K |
7 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
3
|
1.3K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
ZolRab
|
43 |
9.2K |
7 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
43
|
9.2K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
ZolRab
|
43 |
9.2K |
4 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
43
|
9.2K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 SCUlpTOR Osteoarthritis Clinical Trial Progress
|
|
ZolRab
|
6 |
1.8K |
13 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
6
|
1.8K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
ZolRab
|
43 |
9.2K |
8 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
43
|
9.2K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Stem Cell News
|
|
ZolRab
|
515 |
124K |
5 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
515
|
124K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
"Good vibes Here Dudes".....
|
|
ZolRab
|
114 |
28K |
12 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
114
|
28K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ZolRab
|
17 |
4.3K |
3 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
17
|
4.3K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ZolRab
|
17 |
4.3K |
3 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
17
|
4.3K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata announces CEO succession and Board changes
|
|
ZolRab
|
84 |
26K |
1 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
84
|
26K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata announces CEO succession and Board changes
|
|
ZolRab
|
84 |
26K |
18 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
84
|
26K
|
18
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease
|
|
ZolRab
|
53 |
11K |
10 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
53
|
11K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Further data supports potency of Cynata MSCs
|
|
ZolRab
|
107 |
26K |
9 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
107
|
26K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Further data supports potency of Cynata MSCs
|
|
ZolRab
|
107 |
26K |
2 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
107
|
26K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Further data supports potency of Cynata MSCs
|
|
ZolRab
|
107 |
26K |
6 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
107
|
26K
|
6
|
|
Charts
|
CYP |
Re:
CYP chart
|
|
ZolRab
|
1.9K |
597K |
10 |
30/06/22 |
30/06/22 |
Charts
|
1.9K
|
597K
|
10
|
|
Charts
|
CYP |
Re:
CYP chart
|
|
ZolRab
|
1.9K |
597K |
13 |
30/06/22 |
30/06/22 |
Charts
|
1.9K
|
597K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
Ann: FDA Clears Cynata IND for Phase 2 Trial in GvHD
|
|
ZolRab
|
73 |
22K |
4 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
73
|
22K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
EGM campaign
|
|
ZolRab
|
75 |
18K |
4 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
75
|
18K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
EGM campaign
|
|
ZolRab
|
75 |
18K |
4 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
75
|
18K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
EGM campaign
|
|
ZolRab
|
75 |
18K |
19 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
75
|
18K
|
19
|
|
ASX - By Stock
|
CYP |
Re:
Stem cell injection for Cyp management
|
|
ZolRab
|
133 |
28K |
4 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
133
|
28K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Stem cell injection for Cyp management
|
|
ZolRab
|
133 |
28K |
13 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
133
|
28K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
The Science Will Do The Talking
|
|
ZolRab
|
219 |
44K |
20 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
219
|
44K
|
20
|
|
ASX - By Stock
|
CYP |
Re:
CYP vs MSB
|
|
ZolRab
|
644 |
126K |
13 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
644
|
126K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Patient Enrolment Opens in COVID-19 Clinical Trial
|
|
ZolRab
|
142 |
40K |
12 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
142
|
40K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Patient Enrolment Opens in COVID-19 Clinical Trial
|
|
ZolRab
|
142 |
40K |
2 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
142
|
40K
|
2
|
|
ASX - By Stock
|
CYP Biotech |
Re:
EGM to remove entire Board
|
|
ZolRab
|
28 |
10K |
5 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
28
|
10K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata announces $5.55m capital raising
|
|
ZolRab
|
149 |
44K |
16 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
149
|
44K
|
16
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata announces $5.55m capital raising
|
|
ZolRab
|
149 |
44K |
11 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
149
|
44K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
ZolRab
|
507 |
1.5M |
23 |
08/02/20 |
08/02/20 |
ASX - By Stock
|
507
|
1.5M
|
23
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
ZolRab
|
507 |
1.5M |
20 |
07/02/20 |
07/02/20 |
ASX - By Stock
|
507
|
1.5M
|
20
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
ZolRab
|
507 |
1.5M |
12 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
507
|
1.5M
|
12
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
ZolRab
|
507 |
1.5M |
19 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
507
|
1.5M
|
19
|
|
ASX - By Stock
|
CYP |
Re:
Resolution seven - privacy or private company!?
|
|
ZolRab
|
78 |
91K |
12 |
19/11/19 |
19/11/19 |
ASX - By Stock
|
78
|
91K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Resolution seven - privacy or private company!?
|
|
ZolRab
|
78 |
91K |
13 |
04/11/19 |
04/11/19 |
ASX - By Stock
|
78
|
91K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
Resolution seven - privacy or private company!?
|
|
ZolRab
|
78 |
91K |
21 |
04/11/19 |
04/11/19 |
ASX - By Stock
|
78
|
91K
|
21
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata & Sumitomo Withdraw from Acquisition Discussions
|
|
ZolRab
|
80 |
37K |
27 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
80
|
37K
|
27
|
|